Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "central nervous system pathways involved in muscle spasm" refer to interconnected neural tracts in the brain and spinal cord, primarily including the corticospinal tract and extrapyramidal systems, which regulate motor neuron excitability, muscle tone, and reflexes. Dysfunction or hyperexcitability in these pathways, due to neurological disease or injury, leads to disordered muscle contractions, increased reflex activity, and clinically manifests as spasticity and muscle spasms. These pathways are complex and include both descending motor control and local spinal circuitry; they are not a single molecular entity but a physiological system composed of multiple neurons, synaptic connections, and neurotransmitter systems, making them unsuitable as a conventional drug target.
GABA receptor agonism (baclofen, diazepam); Alpha-2 adrenergic receptor agonism (tizanidine); Direct muscle relaxation via ryanodine receptor inhibition (dantrolene); Inhibition of acetylcholine release at neuromuscular junction (botulinum toxin); Unknown/complex: quinine (alters muscle excitability)
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system pathways involved in muscle spasm.